Le Lézard
Classified in: Health
Subject: OFR

Trulieve Announces Completion of Redemption of All US$130 Million 9.75% Senior Secured Notes due 2024


TALLAHASSEE, Fla., Dec. 1, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it has completed the redemption of all US$130,000,000 (Cdn$175,669,000) principal amount of its outstanding 9.75% senior secured notes due 2024 (CUSIP: 89788CAB0 / ISIN: CA89788CAB06) (the "Notes"). Cash used for the redemption was approximately US$136 million (Cdn$184 million), which included the aggregate principal amount of the Notes being redeemed, plus accrued and unpaid interest to, but excluding, the redemption date of December 1, 2023. The Notes will cease to trade on the Canadian Securities Exchange under the symbol "TRUL.DB.U" as of the close of trading on December 1, 2023 and will be delisted as of December 1, 2023.  Additional information regarding the redemption of the Notes is available from Odyssey Trust Co.

This press release is for information purposes only and is not an offer to purchase, a solicitation of an offer to sell the Notes or any other securities of the Company.

Forward-Looking Statements
This news release includes forward-looking information and statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to the Company's expectations or forecasts other plans, intentions, expectations, estimates, and beliefs and include statements regarding the date the Notes will cease to trade and will be delisted from the Canadian Securities Exchange. Words such as "expects", "continue", "will", "anticipates" and "intends" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on the Company's current projections and expectations about future events and trends that management believes might affect its financial condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors management believes are appropriate. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risks discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and in our periodic reports subsequently filed with the United States Securities and Exchange Commission and in the Company's filings on SEDAR at www.sedar.com. There can be no assurance that any forward-looking information and statements herein will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve 

Investor Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
[email protected]

Media Contact
Phil Buck, Corporate Communications Manager
+1 (406) 370-6226
[email protected] 

SOURCE Trulieve Cannabis Corp.


These press releases may also interest you

at 14:18
Sun Life U.S. has released reports from two clinical intervention programs offered to eligible members receiving disability or critical illness benefits. The reports showed that members who used these programs experienced improved health outcomes....

at 14:12
The antiemetics drugs market size is estimated to grow by USD 1.63 billion at a CAGR of 6.47% between 2022 and 2027.  The increasing healthcare expenditure is a key factor driving market growth. Global health spending rises due to factors like...

at 14:09
Ochsner Digital Medicine has partnered with Humana Healthy Horizons to provide digital medicine services to its members. This agreement was effective February 1, 2024, with member enrollment in digital programs available immediately after....

at 14:07
In a significant move towards public safety and uniform industry practices, DIZPOT, a trailblazer in cannabis packaging, has voiced their support for the regulatory milestones in both Missouri and Arizona. Missouri's Senate Bill 984 The Intoxicating...

at 14:00
The Kettle Society is pleased to announce the appointment of Wayne Leslie as its new Executive Director, effective April 2nd, 2024. Leslie will succeed Nancy Keough, who is retiring after 43 years of service with The Kettle, including 34 years as...

at 14:00
SummaryProduct: Counterfeit Viagra, 100 mg sildenafil tablets; counterfeit Cialis, 20 mg tadalafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of these products. Consult...



News published on and distributed by: